Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Suzetrigine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vertex Dips on Mixed Ph 2 Data for Non-Opioid Pain Therapy
    Vertex Dips on Mixed Ph 2 Data for Non-Opioid Pain Therapy

    20 Dec 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/vertex-dips-on-mixed-phase-ii-data-for-non-opioid-pain-therapy

    BIOSPACE
    20 Dec 2024
    Share Share
    Channel Therapeutics Highlight NaV1.7 vs NaV1.8 in Suzetrigine
    Channel Therapeutics Highlight NaV1.7 vs NaV1.8 in Suzetrigine

    20 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/20/3000627/0/en/Channel-Therapeutics-Highlights-Differences-Between-NaV1-7-and-NaV1-8-in-Light-of-Recent-Clinical-Data-on-Suzetrigine.html

    GLOBENEWSWIRE
    20 Dec 2024
    Share Share
    Vertex Reports First Quarter 2024 Financial Results
    Vertex Reports First Quarter 2024 Financial Results

    06 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240506449207/en

    BUSINESSWIRE
    06 May 2024
    Share Share
    Vertex announces advancements of pain signal inhibitor, suzetrigine
    Vertex announces advancements of pain signal inhibitor, suzetrigine

    20 Apr 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168666&sid=2

    PHARMABIZ
    20 Apr 2024
    Share Share
    Vertex Updates On Suzetrigine For Acute And Neuropathic Pain
    Vertex Updates On Suzetrigine For Acute And Neuropathic Pain

    18 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240418505520/en

    BUSINESSWIRE
    18 Apr 2024
    Share Share